Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

TOP NEWS: AstraZeneca wins three approvals in EU for cancer drugs

22nd Feb 2023 09:11

(Alliance News) - AstraZeneca PLC on Wednesday said its Imfinzi and Imjudo were approved in the European Union for the treatment of advanced liver and lung cancers. Its Calquence was also approved to treat chronic lymphocytic leukaemia. Read More

LONDON BROKER RATINGS: BoA cuts DS Smith; Jefferies likes JTC

21st Feb 2023 10:17

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

AstraZeneca reports protection against RSV in infants with Beyfortus

21st Feb 2023 09:42

(Alliance News) - AstraZeneca PLC on Tuesday said Beyfortus continues to show consistent protection against respiratory syncytial virus in infants. Read More

UK dividends calendar - next 7 days

16th Feb 2023 15:47

Read More

AstraZeneca's Evusheld not recommended by NHS for vulnerable people

15th Feb 2023 14:30

(Alliance News) - The Covid drug Evusheld will not be recommended by the NHS for people with weakened immune systems. Read More

LONDON BROKER RATINGS: Bryan Garnier starts Unilever with 'neutral'

15th Feb 2023 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

LONDON MARKET CLOSE: Rate worries keep European stocks in check

10th Feb 2023 16:55

(Alliance News) - Stock prices in London closed lower on Friday, as news that the UK managed to avert a recession failed to inspire equities, with interest rate worries hanging over markets again. Read More

UPDATE: Hunt disappointed UK loses new AstraZeneca factory to Ireland

10th Feb 2023 10:32

(Alliance News) - Chancellor Jeremy Hunt said he was disappointed the UK "lost out this time" on a GBP320 million new AstraZeneca PLC factory after the pharmaceutical company chose the low-tax Republic of Ireland instead. Read More

Hunt disappointed UK 'lost out this time' on new AstraZeneca factory

10th Feb 2023 10:27

(Alliance News) - UK Chancellor Jeremy Hunt said he was disappointed the UK "lost out this time" on a GBP320 million new AstraZeneca PLC factory after the pharmaceutical company chose the low-tax Republic of Ireland instead. Read More

LONDON MARKET CLOSE: BoE chief lifts FTSE 100; Disney up in New York

9th Feb 2023 16:58

(Alliance News) - London's FTSE 100 hit another record high on Thursday as largely soothing words from the Bank of England governor lifted the mood, while equities in New York joined in on the action, with Walt Disney a star performer. Read More

LONDON MARKET MIDDAY: Standard Chartered takeover talks lift FTSE 100

9th Feb 2023 12:05

(Alliance News) - Stock prices in London were largely higher at midday on Thursday, thanks to a strong set of results from drug maker AstraZeneca and renewed takeover talks for lender Standard Chartered. Read More

AstraZeneca has the pipeline to sustain "longer-term growth" - Shore

9th Feb 2023 11:06

(Alliance News) - AstraZeneca PLC reported a swing to full-year profit and saw a double-digit revenue rise on Thursday, despite a weaker fourth quarter. Read More

LONDON MARKET OPEN: BAT falls on sales miss; Entain hit by MGM remark

9th Feb 2023 09:13

(Alliance News) - Stock prices in London opened higher on Thursday, as investors digested a mixed set of UK company earnings. Read More

TOP NEWS: AstraZeneca swings to profit as Alexion adds to 2022 revenue

9th Feb 2023 08:42

(Alliance News) - AstraZeneca PLC on Thursday reported a swing to full-year profit and saw a double-digit revenue rise, despite a weaker fourth quarter. Read More

LONDON BRIEFING: AstraZeneca swings to profit; Unilever volumes fall

9th Feb 2023 07:55

(Alliance News) - Stocks in London were called to open higher on Thursday, as investors in Europe kept their cool, despite hawkish US central bankers and a weak finish on Wall Street. Read More

CORRECT: EU approves AstraZeneca's Forxiga for chronic heart failure

7th Feb 2023 08:23

(Corrects share price information.) Read More

TOP NEWS: EU approves AstraZeneca's Forxiga for chronic heart failure

7th Feb 2023 08:05

(Alliance News) - AstraZeneca PLC on Tuesday announced that the EU has approved its drug Forxiga for the treatment of symptomatic chronic heart failure. Read More

UK earnings, trading statements calendar - next 7 days

2nd Feb 2023 15:49

Read More

TOP NEWS: AstraZeneca's, Amgen's Tezspire pre-filled pen wins approval

2nd Feb 2023 14:50

(Alliance News) - AstraZeneca PLC and Amgen Inc on Thursday said their severe asthma drug Tezspire has been approved in the form of a pre-filled pen by the US Food & Drug Administration for self-administration for people aged 12 and over. Read More

Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment

30th Jan 2023 16:35

(Alliance News) - Daiichi Sankyo Co Ltd on Monday said the first patient has been dosed in its Tropion-Lung07 phase 3 trial, which is evaluating a combination of treatments for patients with metastatic non-small cell lung cancer. Read More

FTSE 100 Latest
Value10,126.78
Change-68.57